BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7738000)

  • 21. The role of protein phosphatases in the expression of inducible nitric oxide synthase in the rat hepatocyte.
    Taylor BS; Liu S; Villavicencio RT; Ganster RW; Geller DA
    Hepatology; 1999 Apr; 29(4):1199-207. PubMed ID: 10094965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenylarsine oxide and vanadate: apparent paradox of inhibition of protein phosphotyrosine phosphatases in rat adipocytes.
    Li J; Elberg G; Shechter Y
    Biochim Biophys Acta; 1996 Jul; 1312(3):223-30. PubMed ID: 8703991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli.
    Traenckner EB; Pahl HL; Henkel T; Schmidt KN; Wilk S; Baeuerle PA
    EMBO J; 1995 Jun; 14(12):2876-83. PubMed ID: 7796813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies into the effect of tyrosine phosphatase inhibitor phenylarsine oxide on NFkappaB activation in T lymphocytes during aging: evidence for altered IkappaB-alpha phosphorylation and degradation.
    Ponnappan U; Trebilcock GU; Zheng MZ
    Exp Gerontol; 1999 Jan; 34(1):95-107. PubMed ID: 10197731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement of nuclear factor-kappaB activation and protein tyrosine phosphorylation by a tyrosine phosphatase inhibitor, pervanadate, involves reactive oxygen species in silica-stimulated macrophages.
    Kang JL; Pack IS; Lee HS; Castranova V
    Toxicology; 2000 Oct; 151(1-3):81-9. PubMed ID: 11074303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha.
    Imbert V; Rupec RA; Livolsi A; Pahl HL; Traenckner EB; Mueller-Dieckmann C; Farahifar D; Rossi B; Auberger P; Baeuerle PA; Peyron JF
    Cell; 1996 Sep; 86(5):787-98. PubMed ID: 8797825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Piceatannol inhibits TNF-induced NF-kappaB activation and NF-kappaB-mediated gene expression through suppression of IkappaBalpha kinase and p65 phosphorylation.
    Ashikawa K; Majumdar S; Banerjee S; Bharti AC; Shishodia S; Aggarwal BB
    J Immunol; 2002 Dec; 169(11):6490-7. PubMed ID: 12444159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenylarsine oxide blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, and induces apoptosis of acute myelogenous leukemia cells.
    Estrov Z; Manna SK; Harris D; Van Q; Estey EH; Kantarjian HM; Talpaz M; Aggarwal BB
    Blood; 1999 Oct; 94(8):2844-53. PubMed ID: 10515888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The mutant plasmacytoma cell line S107 allows the identification of distinct pathways leading to NF-kappaB activation.
    Baumann B; Kistler B; Kirillov A; Bergman Y; Wirth T
    J Biol Chem; 1998 May; 273(19):11448-55. PubMed ID: 9565556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Capsaicin (8-methyl-N-vanillyl-6-nonenamide) is a potent inhibitor of nuclear transcription factor-kappa B activation by diverse agents.
    Singh S; Natarajan K; Aggarwal BB
    J Immunol; 1996 Nov; 157(10):4412-20. PubMed ID: 8906816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acquisition of cellular resistance to 9-nitro-camptothecin correlates with suppression of transcription factor NF-kappa B activation and potentiation of cytotoxicity by tumor necrosis factor in human histiocytic lymphoma U-937 cells.
    Singh S; Raju U; Mendoza J; Pantazis P; Aggarwal BB
    Anticancer Drugs; 1998 Sep; 9(8):703-14. PubMed ID: 9823429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reconstitution of nuclear factor kappa B activation induced by tumor necrosis factor requires membrane-associated components. Comparison with pathway activated by ceramide.
    Reddy SA; Chaturvedi MM; Darnay BG; Chan H; Higuchi M; Aggarwal BB
    J Biol Chem; 1994 Oct; 269(41):25369-72. PubMed ID: 7929233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oleandrin suppresses activation of nuclear transcription factor-kappaB, activator protein-1, and c-Jun NH2-terminal kinase.
    Manna SK; Sah NK; Newman RA; Cisneros A; Aggarwal BB
    Cancer Res; 2000 Jul; 60(14):3838-47. PubMed ID: 10919658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ET-18-OCH3 inhibits nuclear factor-kappa B activation by 12-O-tetradecanoylphorbol-13-acetate but not by tumor necrosis factor-alpha or interleukin 1 alpha.
    Daniel LW; Civoli F; Rogers MA; Smitherman PK; Raju PA; Roederer M
    Cancer Res; 1995 Nov; 55(21):4844-9. PubMed ID: 7585518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of lysine residues required for signal-induced ubiquitination and degradation of I kappa B-alpha in vivo.
    Rodriguez MS; Wright J; Thompson J; Thomas D; Baleux F; Virelizier JL; Hay RT; Arenzana-Seisdedos F
    Oncogene; 1996 Jun; 12(11):2425-35. PubMed ID: 8649784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NF kappa b signaling in posthypoxic endothelial cells: relevance to E-selectin expression and neutrophil adhesion.
    Kokura S; Rhoads CA; Wolf RE; Yoshikawa T; Granger DN; Aw TY
    J Vasc Res; 2001; 38(1):47-58. PubMed ID: 11173994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calagualine inhibits nuclear transcription factors-kappaB activated by various inflammatory and tumor promoting agents.
    Manna SK; Bueso-Ramos C; Alvarado F; Aggarwal BB
    Cancer Lett; 2003 Feb; 190(2):171-82. PubMed ID: 12565172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methotrexate suppresses NF-kappaB activation through inhibition of IkappaBalpha phosphorylation and degradation.
    Majumdar S; Aggarwal BB
    J Immunol; 2001 Sep; 167(5):2911-20. PubMed ID: 11509639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor necrosis factor activation of the sphingomyelin pathway signals nuclear factor kappa B translocation in intact HL-60 cells.
    Yang Z; Costanzo M; Golde DW; Kolesnick RN
    J Biol Chem; 1993 Sep; 268(27):20520-3. PubMed ID: 8376408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protease inhibitors differentially regulate tumor necrosis factor-induced apoptosis, nuclear factor-kappa B activation, cytotoxicity, and differentiation.
    Higuchi M; Singh S; Chan H; Aggarwal BB
    Blood; 1995 Sep; 86(6):2248-56. PubMed ID: 7662972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.